Mounjaro®
Starting from £179.99/mo
Start journey Learn moreWegovy is available on the NHS, but whether your GP can prescribe it directly depends on where you live, which NHS phase you fall into, and whether your practice has opted in to the new prescribing arrangements. Most people asking this question right now will either face a waiting list or find they don't yet meet the current NHS criteria — though that picture is changing. Wegovy is a prescription-only medicine; a clinician must assess your suitability before any supply is made, regardless of the route you take.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
The short answer is: technically yes, but in practice very few GPs are doing it. NICE approved semaglutide (Wegovy) for NHS use in 2023 under NICE Technology Appraisal TA875, but the guidance ties access firmly to specialist weight management services. That means the patient's care is supposed to sit within a multidisciplinary team rather than a standard GP appointment. Prescribing outside that framework isn't what the NICE recommendation is designed to support.
From April 2026, NHS England updated the GP contract to allow practices to prescribe tirzepatide (Mounjaro) in primary care for certain patients with very high BMIs and multiple conditions. Wegovy doesn't yet have the same primary-care prescribing pathway. So even a GP who wants to help may find their hands are tied by commissioning rules in their area. If you've been told to ask your GP about Wegovy, it's worth checking what your integrated care board currently funds, because the answer varies by region.
Scotland, Wales and Northern Ireland run different access schemes with different thresholds, if that applies to you, NHS England's weight-management injections guidance covers the England picture, and your devolved health board is the place to check local eligibility.
Under TA875, NHS semaglutide is recommended for adults with a BMI of 35 or above and at least one weight-related condition (such as type 2 diabetes, high blood pressure, or obstructive sleep apnoea), and only within a specialist weight management service. For people from South Asian, Chinese, Middle Eastern, Black African or African-Caribbean backgrounds, the thresholds are 2.5 kg/m² lower throughout. The guidance also specifies that treatment runs for a maximum of two years, and if less than 5% weight loss is achieved after six months on the maintenance dose, continuing is reviewed.
That upper BMI threshold means a lot of people who would genuinely benefit (those with a BMI of 30 to 34 with significant health conditions) don't currently qualify on the NHS at all. If you're unsure where you sit, the NHS BMI calculator is a useful starting point, though BMI is only one piece of the clinical picture. Our guide to the BMI needed for Wegovy goes into more detail on how thresholds work in practice.
Even if you meet the numbers, getting a referral to a specialist weight management service with capacity can take a long time. Waiting lists in many areas run to months. That's the practical reality for most people right now.
Yes, and it's the route most people who ask this question end up taking. Any GPhC-registered prescriber can issue a private prescription for Wegovy if you're clinically suitable, without the NHS commissioning rules that restrict access in primary care. The licensed criteria for private prescribing broadly follow the SmPC: adults with a BMI of 30 or above, or 27 or above with at least one weight-related condition, assessed individually by the prescriber.
Through a regulated online pharmacy like nume, the process works differently from a GP appointment in a few practical ways. There are no referrals to chase or waiting rooms to sit in. A GPhC-registered Independent Prescriber reviews your consultation the same day, a real clinician reads your answers, not a piece of software. If you're clinically suitable, your prescription is raised and your treatment is dispatched. If you tend to order things at the start of the month when payday clears, it's worth knowing that orders placed before 12pm Monday to Friday are dispatched the same day once approved, arriving the next working day.
For context on what private treatment costs and what a legitimate price actually includes, our overview of Wegovy costs and free NHS routes is worth reading alongside this. And if you'd like to understand more about what makes a Wegovy provider trustworthy, you can verify any UK online pharmacy on the GPhC register before you commit to anything.
If you're already on Wegovy through another provider and want to move your care, a private pharmacy can usually support this. The prescriber will want to see evidence of your current dose and recent treatment history before continuing or adjusting. This matters because dose increases should always be clinically reviewed, not just assumed. Our Wegovy treatment page covers what the assessment involves for new and transfer patients alike.
One thing to flag for anyone considering taking a break mid-treatment: there are clinical considerations around pausing semaglutide that are worth understanding before you do it. Our guide on taking a break from Wegovy explains what the evidence and guidance say. These are the kinds of questions that a prescriber can answer based on your specific situation, which is why the consultation matters beyond the initial approval.
If you've read this far and you're wondering whether your BMI qualifies for private treatment, our guide to Wegovy eligibility thresholds sets out how the numbers work. And if you're ready to speak to a prescriber directly, the consultation is free and there's no obligation to continue.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.